Context Therapeutics Inc. (CNTX)

Context Therapeutics Statistics

Total Valuation

CNTX has a market cap or net worth of $198.46 million. The enterprise value is $144.21 million.

Market Cap	198.46M
Enterprise Value	144.21M

Important Dates

The last earnings date was Wednesday, May 6, 2026, after market close.

Earnings Date	May 6, 2026
Ex-Dividend Date	n/a

Share Statistics

CNTX has 91.88 million shares outstanding. The number of shares has increased by 21.69% in one year.

Current Share Class	91.88M
Shares Outstanding	91.88M
Shares Change (YoY)	+21.69%
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	1.36%
Owned by Institutions (%)	28.91%
Float	42.82M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.80
P/TBV Ratio	3.80
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.96, with a Debt / Equity ratio of 0.01.

Current Ratio	8.96
Quick Ratio	8.34
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -56.19% and return on invested capital (ROIC) is -37.86%.

Return on Equity (ROE)	-56.19%
Return on Assets (ROA)	-35.83%
Return on Invested Capital (ROIC)	-37.86%
Return on Capital Employed (ROCE)	-83.17%
Weighted Average Cost of Capital (WACC)	12.87%
Revenue Per Employee	n/a
Profits Per Employee	-$2.68M
Employee Count	15
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +173.42% in the last 52 weeks. The beta is 1.57, so CNTX's price volatility has been higher than the market average.

Beta (5Y)	1.57
52-Week Price Change	+173.42%
50-Day Moving Average	2.60
200-Day Moving Average	1.65
Relative Strength Index (RSI)	39.60
Average Volume (20 Days)	818,125

Short Selling Information

The latest short interest is 898,683, so 0.98% of the outstanding shares have been sold short.

Short Interest	898,683
Short Previous Month	863,742
Short % of Shares Out	0.98%
Short % of Float	2.10%
Short Ratio (days to cover)	1.00

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-43.52M
Pretax Income	-40.23M
Net Income	-40.23M
EBITDA	-43.50M
EBIT	-43.52M
Earnings Per Share (EPS)	-$0.42

Balance Sheet

The company has $54.53 million in cash and $282,424 in debt, with a net cash position of $54.25 million or $0.59 per share.

Cash & Cash Equivalents	54.53M
Total Debt	282,424
Net Cash	54.25M
Net Cash Per Share	$0.59
Equity (Book Value)	52.20M
Book Value Per Share	0.57
Working Capital	51.98M

Cash Flow

In the last 12 months, operating cash flow was -$32.79 million and capital expenditures -$37,258, giving a free cash flow of -$32.82 million.

Operating Cash Flow	-32.79M
Capital Expenditures	-37,258
Depreciation & Amortization	16,883
Net Borrowing	n/a
Free Cash Flow	-32.82M
FCF Per Share	-$0.36

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CNTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-21.69%
Shareholder Yield	-21.69%
Earnings Yield	-20.27%
FCF Yield	-16.54%

Analyst Forecast

The average price target for CNTX is $6.00, which is 205.56% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$6.00
Price Target Difference	205.56%
Analyst Consensus	Strong Buy
Analyst Count	10
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1